Aims: To clarify the correlation between chronic sleep restriction (CSR) and sporadic Alzheimer disease (AD), we determined in wild-type mice the impact of CSR, on cognitive performance, beta-amyloid (Ab) peptides, and its feed-forward regulators regarding AD pathogenesis. Methods: Sixteen nine-month-old C57BL/6 male mice were equally divided into the CSR and control groups. CSR was achieved by application of a slowly rotating drum for 2 months. The Morris water maze test was used to assess cognitive impairment. The concentrations of Ab peptides, amyloid precursor protein (APP) and b-secretase 1 (BACE1), and the mRNA levels of BACE1 and BACE1-antisense (BACE1-AS) were measured. Results: Following CSR, impairments of spatial learning and memory consolidation were observed in the mice, accompanied by Ab plaque deposition and an increased Ab concentration in the prefrontal and temporal lobe cortex. CSR also upregulated the b-secretaseinduced cleavage of APP by increasing the protein and mRNA levels of BACE1, particularly the BACE1-AS. Conclusions: This study shows that a CSR accelerates AD pathogenesis in wild-type mice. An upregulation of the BACE1 pathway appears to participate in both cortical Ab plaque deposition and memory impairment caused by CSR. BACE1-AS is likely activated to initiate a cascade of events that lead to AD pathogenesis. Our study provides, therefore, a molecular mechanism that links CSR to sporadic AD.
Introduction
Lack of sleep has become a pervasive trend in our current society. Adequate sleep contributes to waste clearance in the brain [1] and memory processing [2] , whereas long-term sleep deprivation impairs brain functions and increases the risk of neurodegenerative diseases [3] , such as Alzheimer disease (AD). Chronic insomnia has been thought as a high risk factor to the development of AD, which is the leading cause of dementia, and in the United States alone, it affects one in eight individuals over the age of 65 [4] [5] [6] [7] [8] . In China, the prevalence of AD in individuals over the age of 60 is approximately 4% [9] , with a higher prevalence in urban areas, which tend to be associated with a less average sleep time compared with rural areas [10] .
AD is typically characterized by cerebral accumulation of extracellular amyloid deposits, which are composed of betaamyloid (Ab) peptides [5, 8] . Increased Ab deposits initiate a cascade of events that lead to the pathogenesis of AD [11] [12] [13] [14] . Ab peptides are formed by the sequential proteolysis of the type 1 membrane protein amyloid precursor protein (APP). The b-site amyloid precursor protein-cleaving enzyme 1 (BACE1) initiates the cleavage of APP to a membrane-bound C-terminal fragment referred to as C99. A second enzyme, referred as c secretase, subsequently cleaves C99 to produce the toxic Ab peptides [15] . As the concentration of soluble Ab increases, it aggregates and becomes insoluble, thus forming the amyloid plaque, contributing to the development of AD [12] . BACE1 is the rate-limiting enzyme and acts as a key regulator of Ab generation [16, 17] . BACE1-antisense (BACE1-AS) is a recently discovered long noncoding RNA that directly regulates the BACE1 level [18, 19] .
The links between sleep loss and AD have drawn substantial attention. Longitudinal studies have demonstrated an increased prevalence of AD in subjects with sleep disorders as compared with the general population [6, [20] [21] [22] . Furthermore, Ab is deposited in the cerebral cortex following sleep deprivation in the APP transgenic (APPswe) or presenilin 1 transgenic (PS1dE9) mouse model. APPswe/PS1dE9 mice comprise a model of familial AD exhibiting mutations that lead to the early-onset accumulation of Ab in the brain [23] [24] [25] . However, familial AD typically accounts for only 5% of the total AD cases [15, 26] . Most AD cases comprise late-onset sporadic AD and have no identified genetic mutations. Therefore, it is critical to determine whether chronic sleep deprivation promotes Ab deposition and increases the risk of AD in a nongenetically predisposed mouse model and in the general population as well.
In this study, 9-month-old, adult and wild-type C57BL/6 mice were subjected to sleep restriction for 2 months using a slowly rotating drum driven by a custom-designed engine. As the lifespan of mice is approximately 2 years, a 2-month sleep restriction is equivalent to 6-8 years in humans. Therefore, this model was used to determine whether long-term sleep deprivation affected cognitive functions and Ab deposition in the brain. To focus on the feed-forward regulation of the Ab peptides, we specifically investigated the transcript levels of BACE1 as well as of BACE1-AS.
Materials and Methods

Mouse Model
This study was approved by the Institutional Animal Care and Use Committee of the Second Military Medical University. C57BL/6 male mice were obtained from SLAC Laboratory Animals (Shanghai, China). The mice were provided with free access to food and water, and they were maintained in plastic cages in a temperature-controlled room (20-22°C) on a 12-h/12-h light/ dark cycle (lights on at 8:00 am) at the animal care center of the Second Military Medical University. Sixteen nine-month-old C57BL/6 mice were divided into two groups of eight mice: the C57BL/6 chronic sleep restriction (CSR) group and the C57BL/6 control group. Mice in both groups were subjected to CSR using rotating plastic drums (40 cm in diameter). The mice were allowed to sleep for 4 h/day at the beginning of the light phase (8:00-12:00) in their home cages [27] . Mice typically sleep 10-12 h each day; thus, 4 h of sleep is not sufficient to fully recover from 20 h of wakefulness. For the remaining 20 h (from 12:00 to 8:00 + 1 day), the animals were kept awake by placing them on a slowly rotating drum (vertically arranged) driven by an engine at a constant speed (0.4 m/min). For the control group, the drum rotated at a faster pace (0.66 m/min) for a shorter period of time (12 h, from 12:00 to 24:00). According to previous studies, physical exercise could benefit cognitive functions [5] [6] [7] . To balance the amount of exercise, we used different rotate speed to maintain the same distance for both groups. A similar protocol of rotate speed has also been used in previous chronic partial sleep deprivation studies [27, 28] . With this protocol, mice in both groups walked the same distance to maintain the same amount of energy consumption. Prior to the start of the experiment, mice were habituated to the experimental apparatus by placing them in the drum for 7 days.
Assessment of Spatial Learning and Memory
The Morris water maze (MWM) test is widely used to assess spatial learning and memory performance in rodents [29] . The apparatus consisted of a black circular tank (120 cm in diameter and 40 cm deep) filled with warm water (22-24°C). The water was made to appear opaque using white nontoxic paint. A transparent platform (8 cm in diameter) was located in the middle of the southwest quadrant and was submerged 0.5 cm below the water surface. Mice were subjected to four consecutive trials between 20:00 and 22:00 each day over a 5-day training period. Each mouse was released from four different positions around the perimeter of the tank (north, northwest, east, and southeast). In each trial, every mouse was allowed to swim until it found the platform (for a maximum of 120 s) and was subsequently left on the platform for 15 s between trials. If the platform was not found in 120 s, the mouse was guided to the platform and remained there for 30 s. The escape latency to find the hidden platform was automatically recorded using a video tracking system (Ji Liang Technology, Shanghai, China). At the end of the training on the fifth day, a probe test was conducted [30] . The platform was removed; each was released from the northeast quadrant and was allowed to swim for 120 s. Memory retention was measured by quantifying the time spent in the target quadrant and the number of crossings over the previous platform location.
Thioflavin S Histofluorescence Staining
Four mice per group were anesthetized with chloral hydrate and perfused with 0.9% NaCl solution, followed by 4% paraformaldehyde in 0.1 M phosphate-buffered saline (PBS). The brains were dissected, immersed in 4% paraformaldehyde in 0.1 M PBS for 4 h, and subsequently transferred to 25% sucrose in PBS until they sank to the bottom. Coronal sections (20 lm) of the brains were cut using a Leica CM1900 cryostat (Leica, Nussloch, Germany) and floated in PBS. The sections were incubated with 1% thioflavin S (T1892, Sigma-Aldrich, Shanghai, China) for 5 min, differentiated twice in 70% ethanol, and washed in 0.1 M PBS solution. Images were obtained using a Nikon DXM1200 digital camera (Nikon Instruments, Tokyo, Japan) attached to a Nikon Eclipse E600 microscope (Nikon Instruments). In consistence with the experimental method described in previous studies [31, 32] , images of thioflavin-S-stained sections were converted to 8-bit gray scale, thresholded to highlight thioflavin-S staining, and analyzed using ImageJ software (http://imagej.nih.gov/ij/). The results were obtained by comparing the optical density.
Western Blotting and ELISA
The remaining four mice in each group were anesthetized as previously described. The prefrontal cortex was dissected on ice immediately after decapitation and subsequently stored at À80°C in a liquid nitrogen container until further use. For Western blotting, the prefrontal cortex tissue was homogenized in RIPA buffer (Beyotime, Haimen, China) containing a protease inhibitor cocktail (complete Mini, Roche, Basel, Switzerland).
The supernatant was collected, and the total protein concentration was determined using a BCA Protein Assay Kit (Beyotime, Shanghai, China). The total amount of proteins from the tissue was subjected to 12% SDS-PAGE and transferred onto a nitrocellulose membrane (Servicebio, Shanghai, China). The membranes were blocked with 5% (w/v) nonfat dried milk in Tris-buffered saline with Tween-20 (TBST; Beyotime, Haimen, China) and were subsequently incubated with primary antibodies at 4°C overnight. The following primary antibodies were used: rabbit antibody anti-APP (1:400; Sigma-Aldrich, St Louis, MO, USA) and rabbit anti-BACE1 (1:1000; Cell Signaling Technology, Danvers, MA, USA). The membranes were washed and incubated with horseradish peroxidase (HRP)-conjugated secondary antibody (1:5000; Abmart, Shanghai, China) for 2 h at room temperature. The film was scanned, and the protein levels were quantified using ImageJ software (http://imagej.nih.gov/ij/ ). The protein band signal intensity comparison was obtained by following the method described by Du et al. [33] and Alikhani et al. [34] . The b-actin (with TBST, 1:500; A1978; SigmaAldrich, St. Louis, MO, USA) was used as the internal reference protein.
The enzyme-linked immunosorbent assay (ELISA) was used to detect Amyloid. The protocol followed the manufacturer's instructions for Ab1-42 ELISA kit (KMB3441; Invitrogen, Carlsbad, CA, USA) and used 5M guanidine HCl for homogenization. The total amyloid, including both soluble and insoluble forms, was quantified by following the UV absorbance at 450 nm using a spectrophotometer (Bio-Rad Model 680 microplate reader; Multiskan FC; Thermo Fisher Scientific Oy, Vantaa, Finland).
Real-Time Polymerase Chain Reaction (RT-PCR)
RNA was extracted from the mouse prefrontal cortex using TRIzol reagent (Invitrogen) by following the manufacturer's protocol and the methods described by Modarresi et al. [35] . Briefly, RNA (1 lg) samples were passed through Qiagen RNeasy columns (Qiagen, Shanghai, China) and subjected to on-column DNAse digestion to remove DNA contamination. The samples were subsequently subjected to first-strand cDNA synthesis using a QuantiTect Reverse Transcript Kit (Qiagen, Shanghai, China). RT-PCR was performed in duplicate at a total volume of 25 lL using 1 lL of cDNA and a QuantiFastSYBR Green PCR Master Mix. PCR was performed using appropriate commercial QuantiTect primers for BACE1 or GAPDH or previously published primers and a probe for BACE1-AS [36] Biological Engineering Technology and Service Co., Ltd., Shanghai, China). PCR was performed at 95°C for 5 min, followed by 40 cycles of 95°C for 10 s and 60°C for 30 s. Correct PCR products were confirmed using agarose gel electrophoresis and a melting-curve analysis. The relative gene expression was calculated using the 2 ÀDDCT method, and the amount of BACE1 mRNA or BACE1-AS was normalized to an endogenous reference gene (GAPDH). The results are expressed as the number of fold change relative to the CTL as described by Nogalska et al. [37] .
Statistical Analysis
The data are expressed as the meanAEstandard error of the mean (SEM). The total differences between the two mouse groups in the escape latency of the MWM test were determined by ANOVA with repeated measures. The data of the probe test, thioflavin-S staining, Western blotting, ELISA, and RT-PCR were analyzed using t-tests. Statistical analysis was performed using SPSS software, version 19.0 (Data Editing for Windows, IBM Corp., Armonk, NY, USA). The presented P values are two-tailed, and a P < 0.05 is considered statistically significant.
Results
Impairment of Spatial Learning and Memory
Our results showed significant differences in the escape latency to find the hidden platform between the two groups (F = 8.07, P = 0.013; Figure 1A ) and also within the training days (F = 38.5, P = 0.000). However, no significant group and training session interaction was found (F = 0.540, P = 0.707). For the probe test, the mice in the CSR group exhibited a lower number of crossings in the area where the platform was previously located (1.25 AE 0.310 vs. 4.13 AE 0.300, t = À6.68, P = 0.000; Figure Figure 2 ). These consistent observations between the histofluorescence and ELISA indicated that both Ab plaque deposition and Ab peptides concentrations were higher after a 2-month sleep restriction in the wild-type mice.
Increased BACE1 and C99, but not APP in the Sleep Restricted Mice
To further assess the dynamic of Ab peptides, we also analyzed the levels of APP, C-terminal fragment (C99) and BACE. Whereas Western blotting did not show any significant increase in the APP Figure 2 Comparison of Ab deposition and protein levels in the prefrontal cortex, the temporal lobe cortex, and the hippocampus. Figure 3 ).
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Increased BACE1 mRNA Levels and BACE1-AS
We subsequently assessed the RNA transcripts of BACE1 and BACE1-AS to determine the feed-forward regulation of Ab peptides. As demonstrated using RT-PCR, the CSR mice showed a 2.72-and a 1.96-fold higher BACE1 mRNA levels, respectively, in the prefrontal cortex (t = 2.28, P = 0.033) and temporal lobe cortex (t = 2.91, P = 0.027) as compared with the control mice. In the hippocampus, however, this increase (1.19-fold) was not significant (t = 0.760, P = 0.474). In consistence with the observed BACE1 levels, the BACE1-AS transcript levels of the CSR mice also increased in the prefrontal cortex (2.14-fold, t = 2.74, P = 0.034) and temporal lobe cortex (2.65-fold, t = 2.66, P = 0.037), but not in the hippocampus (1.09-fold, t = 0.364, P = 0.729; Figure 4 ).
Discussion
Our study demonstrated that, following a 2-month sleep restriction, the wild-type C57BL/6 mice displayed impairments in spatial learning and memory consolidation, accompanied by Ab deposition in the prefrontal and temporal lobe cortices. To the best of our knowledge, the current findings constitute the first report on an upregulation of the BACE-1 pathway after CSR in wide-type mice, including an increase in both gene expression and mRNA, especially the BACE1-AS transcript levels. As no difference in APP was identified between the CSR and control mice, we suggest that CSR only influences the process after its production. We note here some considerations of the methods used. It is well established that the slowly rotating drum model used in this study affects all sleep stages, while another common used method, multiple platforms on a water tank, causes selective REM sleep deprivation [38] [39] [40] . As we did not perform the electroencephalography (EEG) and electromyography (EMG) to precisely 
(E) (F) Figure 3 BACE1, C99, and APP protein levels in the prefrontal cortex, the temporal lobe cortex, and the hippocampus. (A, B) CSR mice exhibited significantly increased BACE1 protein levels in the prefrontal cortex and the temporal lobe cortex, rather than hippocampus, compared with the CTL mice as detected by Western blotting. (C, D) CSR mice had significantly increased C99 protein levels in the prefrontal cortex and the temporal lobe cortex, rather than hippocampus, compared with the CTL mice. (E, F) Similar levels of APP protein in the prefrontal cortex, the temporal lobe cortex, and the hippocampus were identified in both groups. *P < 0.05; **P < 0.01. determine the sleep stages affected by our CSR protocol, this may be a limitation. However, we emphasize here that the aim of this study was to assess the consequences of a general and partial CSR on the biological markers involved in the AD pathogenesis. Therefore, a CSR by slowly rotating drum model would appear suited to generate a partial loss of all sleep stages with limited stress and thus to mimic partial sleep restriction encountered in our current human society. Nevertheless, given that some effects of CSR on the AD markers are now identified in the present study, the specific effects of a single sleep stage, notably REMs and SWS, should be assessed in the immediate next studies.
Chronic Sleep Restriction and Accumulation of Beta-Amyloid Peptides
Both AD mouse models and patients with genetic mutations could facilitate amyloid protein pathogenesis that leads to early-onset AD [23, 24, [41] [42] [43] . Studies in AD mouse models have demonstrated that diurnal fluctuations in the concentrations of soluble Ab occur in the interstitial fluid during normal sleep-wake patterns [23, 43] . Soluble Ab increases significantly following acute sleep deprivation and decreases following sleep recovery [23] . However, to date, no study has shown direct evidence of Ab plaque produced by CSR in wild-type mice. In addition, the brain regions with Ab deposition might be different according to variant genetic background. For example, a study in APPswe/PS1dE9 transgenic mice has showed Ab plaque in the olfactory bulb, cingulate, piriform, and entorhinal cortical areas and the hippocampus after a 21-day mild sleep restriction [23] ; another study in 39 TgAD mice has reported increased Ab levels and Ab plaque deposition in the cortex rather than in the hippocampus, after 6-week mild CSR [24] . Therefore, the brain regions with Ab plaque in this study appeared different from those in TgAD mouse studies. Indeed, our findings in wild-type adult mice suggest that the prefrontal and temporal lobe cortices are more vulnerable to Ab deposition than the hippocampus. Finally, as we found that CSR promoted Ab deposition and increases the risk of AD in a nongenetically predisposed wild-type mice, these findings also allow us to suggest a causal link between CSR and late-onset sporadic AD, the major form of the disease. According to the amyloid cascade hypothesis, accumulation of Ab peptides in extracellular space is the primary influence driving AD pathogenesis [44] . Both Ab40 and Ab42 are important isoforms of amyloid protein. Compared with Ab40, Ab42 is more amyloidogenic [45] and of higher cellular toxicity [46] and relates directly to the AD pathology [47] . It has been shown that the vast majority of early stage Ab deposition is composed of Ab42 [48] . In the preclinical stages of AD, soluble Ab becomes insoluble and aggregates into amyloid plaques, resulting in a reduction in the soluble Ab levels in the cerebrospinal fluid [12] . Previous studies have suggested that the soluble Ab oligomers have more cellular toxicity and cause more synaptic impairment than the fibrillar amyloid deposits in the AD process [48, 49] , while the Ab plaques might correlate with the severity of AD [50] . In this study, we measured the concentrations of both soluble and insoluble Ab forms, offering better insights into the Ab burden in the brain than simply measuring any single form of the Ab. Moreover, the observed increase in the concentrations of C99 and Ab, but not of APP, strongly suggests that the upregulation of the BACE1 pathway contributes to Ab deposition in wild-type animals caused by CSR.
Chronic Sleep Restriction Accelerates Ab Accumulation by Upregulating the BACE1 Pathway
Among the series of sequence in Ab generation, BACE1 is the major b-secretase in neurons that regulates Ab generation [44] . It is generally considered as a key and strong promoter of Ab generation, even though inhibition of BACE1 might be free of AD onset. In a recent study, BACE1 knockout mice appear phenotypically normal, yet, they lack Ab in the brain [51] . This observation is reinforced by the findings that BACE1 deficiency rescues memory deficits and cholinergic dysfunction in the Tg2576 AD model [52] . Moreover, BACE1 appears vulnerable, it could be affected by hypoxia and brain vascular diseases, and therefore, it can facilitate the AD process [53, 54] .
Although BACE1 has been considered to be at the root of a toxic vicious cycle that is linked to cognitive impairments in multiple pathogenesis [16] , recent studies have shown that BACE1 acts on the P-selectin glycoprotein ligand 1, which mediates leukocyte adhesion in inflammatory reactions in vitro [55] . BACE1 also disrupts the cellular production of several molecules required for protein kinase A function, causing impairment of memory processing, which is independent of Ab toxicity [56] . In addition, BACE1 can reduce neuronal glucose oxidation and metabolism, therefore affecting the AD progression [57, 58] . The increased BACE1 protein and mRNA transcript as observed in this study suggest that BACE1 might impact AD processing and cognitive impairments via the multiple levels involved in the AD pathogenesis.
Chronic Sleep Restriction Upregulates the BACE1 pathway by enhancing BACE1-Antisense
Numerous protein-coding messenger RNAs have natural antisense transcript partners, most of which seem to be long noncoding RNAs. Among this group, BACE1-AS is well recognized because it acts as a crucial enzyme for BACE1 [18, 36, 59] . In both transgenic AD mouse models and patients, elevated levels of BACE1-AS seem to enhance the Ab burden, thus regulate the AD pathogenesis as a feed-forward pathway [19, 60] . The BACE1-AS upregulates the BACE1 mRNA and BACE1 protein expression, both in vitro and in vivo [37, 61] , while decreased Ab production and deposition have been identified in BACE1-AS knockout mice (Tg-19959) [36] . Our data suggest that a CSR-induced increase in BACE1-AS may initiate the cascade of Ab events leading to AD pathogenesis. BACE1 has long been considered as a target for the AD therapy, yet the development of BACE1 inhibitors has encountered overwhelming difficulties due to inherent disadvantages and undesirable side effects [62] . Therefore, inhibition of BACE1-AS, and subsequently downregulation of BACE1 expression, might constitute the next promising target to protect neurons from Ab burden or to delay AD pathogenesis [63] . As the pathology of AD emerges prior to any symptoms, with the initial identifiable changes occurring about 10-15 years before the cognitive symptoms [5] , the long-term impairments of CSR should be further investigated.
Conclusions
This study shows that chronic sleep restriction accelerates AD pathogenesis in wild-type mice. The upregulation of the BACE1 pathway appears to participate in both cortical Ab plaque deposition and memory impairment caused by chronic sleep restriction. BACE1-AS is likely activated to initiate a cascade of events that lead to AD pathogenesis. Our study provides, therefore, a molecular mechanism that links chronic sleep restriction to sporadic AD.
